The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

被引:0
|
作者
Luca Valenti
Anna Ludovica Fracanzani
Silvia Fargion
机构
[1] Università degli Studi di Milano,Department of Internal Medicine
[2] Padiglione Granelli,undefined
[3] Ospedale Policlinico IRCCS,undefined
来源
Seminars in Immunopathology | 2009年 / 31卷
关键词
Cytokine; Insulin resistance; Inflammation; Kupffer cell; Steatosis;
D O I
暂无
中图分类号
学科分类号
摘要
Alcoholic liver disease and nonalcoholic liver disease represent a leading cause of liver disease and share similar pathogenic mechanisms among which activation of the immune system plays a key role. The main events consist in (a) activation of Kupffer cells via TLR-4 by LPS and fatty acids (b) complement activation (c) increased release of proinflammatory mediators (d) alteration in NK and NKT cell number/activity (e) activation of the adaptive immune system. At the same time, activation of intracellular pro-inflammatory pathways by cytokines and bacterial products, inhibit insulin signaling favoring lipogenesis, metabolic alterations, and cell damage.
引用
收藏
页码:359 / 369
页数:10
相关论文
共 50 条
  • [41] Introduction: Innate immune responses in progression of alcoholic and nonalcoholic steatohepatitis
    Ikejima, K.
    Kon, K.
    Aoyama, T.
    Yamagata, H.
    Okumura, K.
    Yamashina, S.
    Enomoto, N.
    Watanabe, S.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2008, 32 (06) : 307A - 307A
  • [42] Histological Features of Cerebellar Neuropathology in Patients With Alcoholic and Nonalcoholic Steatohepatitis
    Balzano, Tiziano
    Forteza, Jeronimo
    Borreda, Irene
    Molina, Pilar
    Giner, Juan
    Leone, Paola
    Urios, Amparo
    Montoliu, Carmina
    Felipo, Vicente
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (09): : 837 - 845
  • [43] NONALCOHOLIC FATTY LIVER DISEASE AND STEATOHEPATITIS
    Colak, Yasar
    Tuncer, Ilyas
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2010, 73 (03): : 85 - 91
  • [44] Disease Progression in a Patient with Nonalcoholic Steatohepatitis
    Tseng, Ping-Huei
    Liu, Chun-Jen
    Kao, Jia-Horng
    Shun, Chia-Tung
    Chen, Pei-Jer
    Chen, Ding-Shinn
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2008, 107 (10) : 816 - 821
  • [45] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Yurie Soejima
    Toshio Fukusato
    World Journal of Gastroenterology, 2012, (19) : 2300 - 2308
  • [46] Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis
    Qamar, Amir A.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 : S28 - S32
  • [47] Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Masayoshi Kage
    Shinichi Aishima
    Hironori Kusano
    Hirohisa Yano
    Journal of Medical Ultrasonics, 2020, 47 : 549 - 554
  • [48] Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management
    Kim, Soo Ki
    Kim, Ke Ih
    Kim, Soo Ryang
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (09): : 1147 - 1153
  • [49] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
    Massoud, Omar
    Charlton, Michael
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 201 - +
  • [50] Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Hung, Chun Kit
    Bodenheimer, Henry C., Jr.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 175 - +